相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector
William D. Pratt et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Potent Vesicular Stomatitis Virus-Based Avian Influenza Vaccines Provide Long-Term Sterilizing Immunity against Heterologous Challenge
Jennifer A. Schwartz et al.
JOURNAL OF VIROLOGY (2010)
A Vesicular Stomatitis Virus-Based Hepatitis B Virus Vaccine Vector Provides Protection against Challenge in a Single Dose
Melissa A. Cobleigh et al.
JOURNAL OF VIROLOGY (2010)
Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2010)
Safety and Immunogenicity of Therapeutic DNA Vaccination in Individuals Treated with Antiretroviral Therapy during Acute/Early HIV-1 Infection
Eric S. Rosenberg et al.
PLOS ONE (2010)
Prospects for immunisation against Marburg and Ebola viruses
Thomas W. Geisbert et al.
REVIEWS IN MEDICAL VIROLOGY (2010)
Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic
Alexander A. Bukreyev et al.
VIROLOGY (2010)
Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species
Lisa E. Hensley et al.
PLOS PATHOGENS (2010)
Postexposure Treatment of Marburg Virus Infection
Thomas W. Geisbert et al.
EMERGING INFECTIOUS DISEASES (2010)
Potential Factors Induced by Filoviruses that Lead to Immune Supression
Mansour Mohamadzadeh
CURRENT MOLECULAR MEDICINE (2009)
Disease modeling for Ebola and Marburg viruses
Dennis Bente et al.
DISEASE MODELS & MECHANISMS (2009)
Therapeutic HPV DNA vaccines
Archana Monie et al.
EXPERT REVIEW OF VACCINES (2009)
Replication-Deficient Ebolavirus as a Vaccine Candidate
Peter Halfmann et al.
JOURNAL OF VIROLOGY (2009)
Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2009)
Ebola outbreak has experts rooting for answers
David Cyranoski
NATURE (2009)
Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule
Nancy J. Sullivan et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
Jason S. Richardson et al.
PLOS ONE (2009)
Mucosal Immunization of Cynomolgus Macaques with the VSVΔG/ZEBOVGP Vaccine Stimulates Strong Ebola GP-Specific Immune Responses
Xiangguo Qiu et al.
PLOS ONE (2009)
EMERGING INFECTIOUS DISEASES: Scientists Puzzle Over Ebola-Reston Virus in Pigs
D. Normile
SCIENCE (2009)
Discovery of Swine as a Host for the Reston ebolavirus
Roger W. Barrette et al.
SCIENCE (2009)
Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007
Eric M. Leroy et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2009)
Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge
Alexander Bukreyev et al.
VIROLOGY (2009)
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Yuliang Sun et al.
VIROLOGY (2009)
Single-dose, therapeutic vaccination of mice with vesicular stomatitis virus expressing human papillomavirus type 16 E7 protein
John B. Liao et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections
Dana L. Swenson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses
Dana L. Swenson et al.
EXPERT REVIEW OF VACCINES (2008)
Current progress of DNA vaccine studies in humans
Shan Lu et al.
EXPERT REVIEW OF VACCINES (2008)
Recombinant vesicular stomatitis virus vector mediates postexposure protection against Sudan Ebola hemorrhagic fever in nonhuman primates
Thomas W. Geisbert et al.
JOURNAL OF VIROLOGY (2008)
Nasal Delivery of an Adenovirus-Based Vaccine Bypasses Pre-Existing Immunity to the Vaccine Carrier and Improves the Immune Response in Mice
Maria A. Croyle et al.
PLOS ONE (2008)
Generation of biologically contained Ebola viruses
Peter Halfmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The global impact of vaccination against hepatitis B: A historical overview
Alessandro R. Zanetti et al.
VACCINE (2008)
Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses
Thomas W. Geisbert et al.
VACCINE (2008)
A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals
Lijuan Yang et al.
VIROLOGY (2008)
SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector
Sagar U. Kapadia et al.
VIROLOGY (2008)
Newly Discovered Ebola Virus Associated with Hemorrhagic Fever Outbreak in Uganda
Jonathan S. Towner et al.
PLOS PATHOGENS (2008)
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
Thomas W. Geisbert et al.
PLOS PATHOGENS (2008)
Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit
Mark G. Kortepeter et al.
EMERGING INFECTIOUS DISEASES (2008)
Studies of reservoir hosts for Marburg virus
Robert Swanepoel et al.
EMERGING INFECTIOUS DISEASES (2007)
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge
Kelly L. Warfield et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice
Ami Patel et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: Identification of alleles associated with fatal and nonfatal disease outcomes
Anthony Sanchez et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever
Steven M. Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Assessment of the risk of Ebola virus transmission from bodily fluids and fomites
Daniel G. Bausch et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Marburg Virus Infection Detected in a Common African Bat
Jonathan S. Towner et al.
PLOS ONE (2007)
Successful topical respiratory tract immunization of primates against ebola virus
Alexander Bukreyev et al.
JOURNAL OF VIROLOGY (2007)
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates
J. Erik Johnson et al.
VIROLOGY (2007)
Protective efficacy of neutralizing antibodies against Ebola virus infection
Ayato Takada et al.
VACCINE (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Effective post-exposure treatment of Ebola infection
Heinz Feldmann et al.
PLOS PATHOGENS (2007)
Filoviruses and the balance of innate, adaptive, and inflammatory responses
Mansour Mohamadzadeh et al.
VIRAL IMMUNOLOGY (2006)
Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice
John S. Lee et al.
VACCINE (2006)
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial
Julie E. Martin et al.
CLINICAL AND VACCINE IMMUNOLOGY (2006)
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine
Kathleen M. Daddario-DiCaprio et al.
JOURNAL OF VIROLOGY (2006)
Generation of an adenoviral vaccine vector based on simian adenovirus 21
Soumitra Roy et al.
JOURNAL OF GENERAL VIROLOGY (2006)
Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies
Ling Ye et al.
VIROLOGY (2006)
Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GPs
Nancy J. Sullivan et al.
PLOS MEDICINE (2006)
Human papillomavirus vaccines
Margaret A. Stanley
REVIEWS IN MEDICAL VIROLOGY (2006)
Ebola virus: unravelling pathogenesis to combat a deadly disease
Thomas Hoenen et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates:: an efficacy assessment
KM Daddario-DiCaprio et al.
LANCET (2006)
Current strategies and future directions for eluding adenoviral vector immunity
Dinesh S. Bangari et al.
CURRENT GENE THERAPY (2006)
Chimpanzee adenovirus vaccine protects against Zaire Ebola virus
GP Kobinger et al.
VIROLOGY (2006)
A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge
A Bukreyev et al.
JOURNAL OF VIROLOGY (2006)
Protective cytotoxic T-cell responses induced by Venezuelan equine encephalitis virus replicons expressing Ebola virus proteins
GG Olinger et al.
JOURNAL OF VIROLOGY (2005)
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses
SM Jones et al.
NATURE MEDICINE (2005)
Development of a new vaccine for the prevention of lassa fever
TW Geisbert et al.
PLOS MEDICINE (2005)
Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates
S Santra et al.
JOURNAL OF VIROLOGY (2005)
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections
DL Swenson et al.
VACCINE (2005)
Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses
M Garbutt et al.
JOURNAL OF VIROLOGY (2004)
Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein
A Roberts et al.
JOURNAL OF VIROLOGY (2004)
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
KL Warfield et al.
VACCINE (2004)
Role of natural killer cells in innate protection against lethal Ebola virus infection
KL Warfield et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Contribution of Ebola virus glycoprotein, nucleoprotein, and VP24 to budding of VP40 virus-like particles
JM Licata et al.
JOURNAL OF VIROLOGY (2004)
Exotic emerging viral diseases: progress and challenges
TW Geisbert et al.
NATURE MEDICINE (2004)
Production of novel Ebola virus-like particles from cDNAs: an alternative to Ebola virus generation by reverse genetics
S Watanabe et al.
JOURNAL OF VIROLOGY (2004)
Persistent infection with Ebola virus under conditions of partial immunity
M Gupta et al.
JOURNAL OF VIROLOGY (2004)
Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: Cellular responses, virus load, and nitric oxide levels
A Sanchez et al.
JOURNAL OF VIROLOGY (2004)
Ebola virus-like particles protect from lethal Ebola virus infection
KL Warfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques - Evidence that dendritic cells are early and sustained targets of infection
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pathogenesis of Ebola hemorrhagic fever in primate models - Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells
TW Geisbert et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event
TW Geisbert et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus
J Riemenschneider et al.
VACCINE (2003)
Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates
NJ Sullivan et al.
NATURE (2003)
A review of human papillomavirus vaccines: From basic science to clinical trials
JM Berry et al.
FRONTIERS IN BIOSCIENCE (2003)
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
PWHI Parren et al.
JOURNAL OF VIROLOGY (2002)
Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily
LE Hensley et al.
IMMUNOLOGY LETTERS (2002)
Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge
JS Kahn et al.
JOURNAL OF VIROLOGY (2001)
An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants
NF Rose et al.
CELL (2001)
Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication
M Gupta et al.
JOURNAL OF VIROLOGY (2001)
Development of a preventive vaccine for Ebola virus infection in primates
NJ Sullivan et al.
NATURE (2000)
Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
P Pushko et al.
VACCINE (2000)
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy
AP Durbin et al.
JOURNAL OF VIROLOGY (2000)
Human asymptomatic Ebola infection and strong inflammatory response
EM Leroy et al.
LANCET (2000)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses
TW Geisbert et al.
LABORATORY INVESTIGATION (2000)
分享论文
